KLRS
Ticker
Kalaris Therapeutics, Inc.
KLRS · Healthcare · Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for…Kalaris Therapeutics, Inc. (KLRS), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 1 corporate insider: 2 purchases and 0 sales, 1 filed past the deadline. Filers took a median of 32 days from execution to disclosure, and the most recent trade was executed May 20 and filed May 22. The most active filer was Srinivas Akkaraju with 2 filings.
Add to watchlistFilings, ttm
2
2 buys · 0 sells · 1 late
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$6.2M
estimated for Congress, as filed for insiders
Median delay
32d
execution to disclosure
Last traded
May 20
Filed May 22
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$4.37 (-0.7%)
Adjusted for splits and dividends.
Volume by month
Buys $6.2M
Sells $0
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
SARecent filings
Srinivas AkkarajuPURCHASE
Director
$1.2M244,300 sh × $4.83
Exec May 20
Filed May 22 · 7:47 PM ET Srinivas AkkarajuPURCHASE Director $5.0M
479,847 sh × $10.42
Exec Dec 18 2025
Filed Feb 17 · 8:15 PM ET †